INVENTIVA ADS/1 O.N. Total Liabilities

Latest as of December 2025: €278.03 Million EUR ≈ $325.05 Million USD

INVENTIVA ADS/1 O.N. total liabilities. Based on the latest financial reports, INVENTIVA ADS/1 O.N. (6IVA) has total liabilities worth €278.03 Million EUR (≈ $325.05 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check INVENTIVA ADS/1 O.N. liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of INVENTIVA ADS/1 O.N. (2021–2025)

Total liabilities of INVENTIVA ADS/1 O.N. from 2021 to 2025. This chart illustrates how INVENTIVA ADS/1 O.N.'s total liabilities have evolved over time, based on quarterly financial data. Explore 6IVA strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

INVENTIVA ADS/1 O.N. Competitors by Total Liabilities

The table below lists competitors of INVENTIVA ADS/1 O.N. ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Luoman Lighting Technologies Inc. SHG:605289	China	CN¥1.55 Billion
Cangzhou Mingzhu Plastic Co Ltd SHE:002108	China	CN¥3.33 Billion
Huaku Development Co Ltd TW:2548	Taiwan	NT$33.06 Billion
Huizhou Speed Wireless Technology Co Ltd SHE:300322	China	CN¥2.41 Billion
Elders Ltd AU:ELD	Australia	AU$2.34 Billion
Lampsa Hellenic Hotels S.A AT:LAMPS	Greece	€150.18 Million
Hengkang Medical Group Co Ltd SHE:002219	China	CN¥4.53 Billion
Ningbo Changhong Polymer Scientific & Technical Inc SHG:605008	China	CN¥4.57 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down INVENTIVA ADS/1 O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of INVENTIVA ADS/1 O.N..

Liquidity & Leverage Metrics

INVENTIVA ADS/1 O.N. Total Liabilities Ratios Explained

INVENTIVA ADS/1 O.N. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-9.75	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how INVENTIVA ADS/1 O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for INVENTIVA ADS/1 O.N. (2021–2025)

The table below shows the annual total liabilities of INVENTIVA ADS/1 O.N. from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€278.03 Million ≈ $325.05 Million	+23.23%
2024-12-31	€225.61 Million ≈ $263.77 Million	+122.08%
2023-12-31	€101.59 Million ≈ $118.77 Million	+44.04%
2022-12-31	€70.53 Million ≈ $82.45 Million	+112.96%
2021-12-31	€33.12 Million ≈ $38.72 Million	--

About INVENTIVA ADS/1 O.N.

F:6IVA Germany Biotechnology

Market Cap

$982.79 Million

€840.63 Million EUR

Market Cap Rank

#8788 Global

#1149 in Germany

Share Price

€4.38

Change (1 day)

-0.45%

52-Week Range

€2.56 - €6.00

All Time High

€15.60